The FDA has approved Exdensur for add-on maintenance treatment of severe asthma characterized by an eosinophilic phenotype in patients aged 12 and older.

Men and women with emphysema benefit from endoscopic lung volume reduction (ELVR), but women may have better symptom response and QoL.

The FDA has approved an oral pellet formulation of Orladeyo® to prevent attacks of hereditary angioedema in pediatric patients.

COVID-19 vaccines given to children last fall helped keep many out of emergency rooms and urgent care, new data shows.

About 9% of patients with inborn errors of immunity/primary immune disorders developed cancer, especially B-NHL, a European study found.

Adult patients with CAP in a low-resource setting who were treated with adjunctive low-dose glucocorticoids had a lower risk of death.

The American Academy of Pediatrics updated its COVID-19 vaccination recommendations for preventing severe disease in children.

The US Food and Drug Administration is considering adding the strongest safety warning available to COVID-19 vaccines.

Integrating lactate assessment with blood pressure evaluation may improve early risk stratification for in-hospital mortality in critically ill adults with COVID-19, as higher lactate concentrations ...